Wade Joanne E, Ledbetter David H, Williams Marc S
Am J Med Genet C Semin Med Genet. 2014 Mar;166C(1):112-6. doi: 10.1002/ajmg.c.31392. Epub 2014 Mar 11.
The United States health care system is undergoing significant change and is seeking innovations in care delivery and reimbursement models that will lead to improved value for patients, providers, payers, and employers. Genomic medicine has the potential to be a disruptive innovation that if implemented intelligently can improve value. The article presents the perspective of the leaders of a large integrated healthcare delivery system regarding the decision to invest in implementation of genomic medicine.
美国医疗保健系统正在经历重大变革，并在寻求护理提供和报销模式方面的创新，这些创新将为患者、医疗服务提供者、付款人和雇主带来更高的价值。基因组医学有可能成为一种颠覆性创新，如果明智地实施，它可以提高价值。本文介绍了一个大型综合医疗保健服务系统的领导者对于投资实施基因组医学这一决策的观点。
